[1]
“INFLIXIMAB AND EMERGING BIOLOGICAL TREATMENT FOR PEDIATRIC CROHN’S DISEASE”, EuroMed Bio J, vol. 4, Apr. 2026, doi: 10.3269/03ae7r94.